GRK2 is a novel early marker of cardiotoxicity in response to doxorubicin
28 May 2018 (08:30 - 18:00)
Organised by:
Abstract
Slides
About the speaker

G. d Annunzio University, Chieti (Italy)
Access the full session
The Event
Heart Failure 2018
28 May 2018
08:30 CET
